Oncodesign Precision Medicine SA (ALOPM)
EU
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Total Revenue | 8.27M | 1.08M |
Operating Income | -1.61M | -9.94M |
Pre Tax Income | -1.72M | -9.85M |
Net Income | -231k | -8.09M |
Preferred Dividends | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.014 | -0.485 |
EBIT | -1.61M | -9.94M |
EBITDA | -1.23M | -9.69M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.